Tesaro
ID: 5177377Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019.
6
Funding Rounds
$457.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Lo**** Mo**** | - | - | - |
| Ma** Ly*** He**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Lo**** Mo**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Tesaro has raised a total of $356m in funding over 6 rounds.
Key Insights:
- Tesaro Venture round, April 18, 2016: $50m
- Tesaro Venture round, March 10, 2016: $155m
- Tesaro Venture round, March 6, 2013: $91m
- Tesaro Series A round, May 28, 2010: $60m
- Tesaro Series B round June 2011: $101m
Industries
Tesaro is active in the following industries: